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Case Report: Pisa Syndrome in Patients with Intellectual 
Disability 
 
Dr Inam Ulhaq, Dr Sutha Murthy, Ijaz Hussain 
      
Abstract 
 
The aim of this report is to describe Pisa syndrome in two adults with intellectual 
disability. This case report is significant as, to our knowledge, Pisa syndrome has 
not previously been reported in an individual with intellectual disability (learning 
disability or mental retardation). Pisa syndrome is a reversible condition 
characterised by sustained flexion of the head and trunk and usually caused by 
psychotropic medication. It may be challenging to identify this condition in 
individuals with intellectual disability who may have coexisting postural and mobility 
problems. Both patients developed sustained involuntary flexion of the trunk and 
head tilt (Pisa syndrome) due to psychotropic medications. Both patients were 
prescribed risperidone, and their condition improved as risperidone was tapered off 
and olanzapine was commenced. Extra vigilance is required to identify Pisa 
syndrome as a reversible side effect of psychotropic medication in people with 
intellectual disability who may have pre-existing mobility and postural abnormalities.  
 
Key words: Pisa Syndrome, Intellectual Disability, Mental Health, Psychotropic 
Medication, Reversible Side Effects 
 
Introduction 
  
Pisa Syndrome (pleurothotonus) was first described by Ekbom in 1972 as a side 
effect of neuroleptic treatment, and defined as sustained involuntary flexion of the 
trunk and head to one side and slight rotation of the body so that the person 
appears like the “leaning Tower of Pisa” (Ekbom, 1972). It is differentiated from 
tardive dyskinesia on the basis of its responsiveness to the withdrawal of 
antipsychotic medication (Suzuki, 2002). Pisa syndrome has been mostly reported 
in association with prolonged use of antipsychotic medication; however, there are 
case reports of its occurrence in association with tricyclic or antiemetic medication, 
cholinesterase inhibitors, without any medication (idiopathic Pisa syndrome), and in 
those with neurodegenerative disorders such as Parkinson disease and Alzheimer 
dementia (Uemura 2008). Little is known about the pharmacological mechanism 
underlying this syndrome. Dopaminergic dysfunction has been implicated. A role for 
serotonergic and noradrenergic mechanisms has also been suggested (Suzuki, 
1997). 
 
A literature search failed to find any case reports of Pisa syndrome in people with 
intellectual disability (learning disability or mental retardation). Both of our patients 
have intellectual disability and developed Pisa syndrome, which responded to 
withdrawal of risperidone. Written consent was obtained from the next of kin for 
each patient as both lacked the capacity to consent for themselves. Ethical approval 
was obtained from the local ethical committee. 
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Case 1 
 
The first patient is a 31-year-old man with severe intellectual disability of unknown 
aetiology and bipolar affective disorder. He also has upper thoracic kyphosis with 
deviation to the right side, which is not prominent and does not affect his 
movements and balance. He developed a marked, sustained, right tilt in his body 
and head with some upward tilt in his neck. He lost weight of 10 kgs over a period of 
4 to 5 months, although his appetite did not change. There was no recent change in 
his medications before the onset of change in his posture. He was prescribed the 
following long-term psychotropic medications for bipolar affective disorder and 
management of his behaviour: risperidone, 6 mg twice a day; carbamazepine, 200 
mg three times a day; diazepam, 10 mg three times a day; and procyclidine, 5 mg 
once a day.  
 
The patient was assessed initially by his general practitioner and then a consultant 
physician to investigate the change in his posture and weight loss. The results of all 
assessments revealed no abnormalities that could explain the weight loss. After 
continuous tilt in his body and head for 4 months, improvement was noted for the 
first time when the dose of risperidone was reduced. The change in his posture 
disappeared when risperidone was discontinued. A retrospective diagnosis of Pisa 
syndrome was made in this case, as other causes for the tilt in his body had been 
ruled out, and his posture responded to reduction and discontinuation of the 
antipsychotic medication. When manic episodes recurred, he was prescribed 
olanzapine, and his condition stabilized on a dose of 10 mg twice a day. The 
carbamazepine was changed to a slow-release formulation for ease of 
administration, and the dose was adjusted to 600 mg twice a day. His weight also 
started to normalize slowly. 
 
Case 2   
  
The second patient is a 46-year-old woman with severe intellectual disabilities, living 
in one of the residential centres for people with learning disability in the West of 
Ireland. Her behaviour problems include pushing and hitting fellow service users and 
staff. She has had a depressive episode. Her prescribed medications included 
risperidone, 2.5 mg twice a day; chlorpromazine, 50 mg twice a day and 25 mg at 
lunchtime; sertraline, 100 mg once a day; and flurazepam, 30 mg at bedtime. She 
developed a sustained left tilt in her body and was holding her left hand in her right 
hand. She lost 8 kgs in 3 months. Her weight loss was associated with poor 
appetite, but the rapidity of the weight loss could not be explained merely by poor 
appetite.  
 
On physical examination, no abnormality was found that could explain her weight 
loss. There was no loss of power in her limbs, and no other neurological deficit could 
be found. The results of all blood tests and computed tomography revealed no 
abnormality. The tilt in her body remained for almost 3 months until the dose of 
risperidone was reduced. With reduction in the risperidone dose, the lean in her 
body slowly improved. Risperidone was discontinued, and the patient was 
prescribed olanzapine for her behaviour. The lean in her body resolved, her appetite 
improved, and she started to gain weight. As in the first case, the diagnosis of Pisa 
syndrome was made retrospectively as all other possible causes for the tilt in her 
body had been ruled out, and improvement occurred with the reduced dose of 
risperidone. 
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Discussion 
 
Pisa syndrome has been reported as common with organic brain syndromes and 
has been reported with neurodegenerative disorders such as Parkinson disease and 
dementia (Suzuki, 2002: 165, Harada, 2006: 771). No report, to our knowledge, 
describes Pisa Syndrome in people with intellectual disability. 
 
We could not explain the weight loss in both cases, although the weight loss in one 
case was associated with poor appetite. In that patient, a depressive episode could 
not be ruled out, but the rapid weight loss could not be explained by only a 
depressive episode. In both cases, the weight loss improved, as did the symptoms 
of Pisa syndrome, when the dose of risperidone was reduced and then 
discontinued. The weight loss could be a side effect of risperidone, but both patients 
had been prescribed risperidone for a long time, and the weight loss coincided with 
the change in body posture. Although there is no reported association of weight loss 
with Pisa syndrome, both of our cases had coexisting weight loss that could not be 
explained otherwise. To establish an association of Pisa syndrome with weight loss, 
more evidence is needed. Both of our patients were prescribed olanzapine after 
discontinuation of risperidone, but there have been case reports where olanzapine 
was the cause of Pisa syndrome (Arora, 2006). Although risperidone was the cause 
of Pisa syndrome in our case, in one case report, it was used to treat a patient who 
developed Pisa syndrome (Harada, 2006: 771). From the reported cases, there is 
no evidence that one psychotropic is more likely than another to cause Pisa 
syndrome, and according to these reports, the psychotropic medication should be 
changed to an appropriate alternative when Pisa syndrome occurs. 
  
Conclusion   
 
Extra caution should be taken with patients who have intellectual disabilities when 
administering psychotropic medications where lack of communication and coexisting 
physical and movement disorders may mask the diagnosis of Pisa syndrome, a 
reversible condition.   
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